Stephen Mok, Ph.D., is an immunologist with over 18 years of experience in cancer immunotherapy, gene and cellular therapy, T-cell biology, and targeted therapies. He earned his Ph.D. at UCLA in the laboratory of Antoni Ribas, developing immunotherapies for melanoma, and completed his postdoctoral training with Nobel Laureate Dr. James Allison at MD Anderson Cancer Center. Stephen specializes in assay development for T-cell potency, multi-color flow cytometry, and mass cytometry. He has extensive experience developing products for clinical trials and translating basic science into clinical applications. Stephen is passionate about advancing cancer treatments and mentoring future scientists.